New drugs for peptic ulcer.
D001549:Benzamides / Q000627:therapeutic use; D001570:Benzodiazepinones / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use / Q000031:analogs & derivatives; D005663:Furans / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010434:Pepsin A / Q000037:antagonists & inhibitors; D010437:Peptic Ulcer / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use; D010890:Pirenzepine; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use; D011899:Ranitidine; D013844:Thiazoles / Q000627:therapeutic use; D014299:Trimipramine / Q000627:therapeutic use
D001549:Benzamides; D001570:Benzodiazepinones; D005663:Furans; D006146:Guanidines; D006635:Histamine H2 Antagonists; D009025:Morpholines; D010276:Parasympatholytics; D010879:Piperazines; D011459:Prostaglandins E, Synthetic; D013844:Thiazoles; D010890:Pirenzepine; D014299:Trimipramine; D002927:Cimetidine; D011899:Ranitidine; C012595:trithiozine; D010434:Pepsin A; C023990:tiotidine